CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
NCT03213678
Clinical Trial Information
Trial Number: NCT03213678 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Miscellaneous
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
- Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
- Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
- Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis For Therapy Choice)- Phase 2 Subprotocol of LY3023414 in Patients With Solid Tumors"
Study ID:
APEC1621D
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT03526250
Clinical Trial Information
Trial Number: NCT03526250 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Miscellaneous
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
- Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
- Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
- Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Palbociclib in Patients With Tumors Harboring Activating Alterations in Cell Cycle Genes"
Study ID:
APEC1621I
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT03220035
Clinical Trial Information
Trial Number: NCT03220035 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Miscellaneous
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
- Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
- Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
- Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Vemurafenib in Patients With Tumors Harboring BRAF V600 Mutations"
Study ID:
APEC1621G
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT03233204
Clinical Trial Information
Trial Number: NCT03233204 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Miscellaneous
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
- Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
- Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
- Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- A Phase 2 Subprotocol of Olaparib in Patients With Tumors Harboring Defects in DNA Damage Repair Genes"
Study ID:
APEC1621H
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT03698994
Clinical Trial Information
Trial Number: NCT03698994 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Miscellaneous
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
- Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
- Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
- Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of BVD-523FB (Ulixertinib) in Patients With Tumors Harboring Activating MAPK Pathway Mutations"
Study ID:
APEC1621J
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT03213665
Clinical Trial Information
Trial Number: NCT03213665 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Miscellaneous
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
- Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
- Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
- Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Tazemetostat in Patients With Tumors Harboring Alterations in EZH2 or Members of the SWI/SNF Complex"
Study ID:
APEC1621C
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT03213691
Clinical Trial Information
Trial Number: NCT03213691 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Miscellaneous
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
- Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
- Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
- Miscellaneous Neoplasm - Solid Tumor
Trial Title:
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Selumetinib (AZD6244 Hydrogen Sulfate) in Patients With Tumors Harboring Activating MAPK Pathway Mutations
Study ID:
APEC1621E
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT00026312
Clinical Trial Information
Trial Number: NCT00026312 (ClinicalTrials.gov)
Disease Type:
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
Trial Title:
Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
Study ID:
ANBL0032
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
NCT00567567
Clinical Trial Information
Trial Number: NCT00567567 (ClinicalTrials.gov)
Disease Type:
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
Trial Title:
Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma
Study ID:
ANBL0532
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Title | Description |
---|---|
NCT00567567-D1 | There is one dataset associated with the publication: NCT00567567-D1. USI is the patient identifier and blanks or "." represent missing data or not applicable for analyses. Data can be used to approximate published study findings, but exact reproduction of previous manuscripts may not be possible in some cases (e.g., when data must be modified for de-identification purposes or have undergone further data cleaning). NCT00567567-D1: There is one row for each patient enrolled on the study ANBL0532. The dataset provides the information necessary to reproduce the manuscript. |
NCT01798004
Clinical Trial Information
Trial Number: NCT01798004 (ClinicalTrials.gov)
Disease Type:
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
Trial Title:
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Study ID:
ANBL12P1
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®